Lapatinib Ditosylate Monohydrate

A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.

Price Not Available inquiry Lapatinib Ditosylate Monohydrate Supplier Page

Catalog Number	API388082788
Alternative Name(s)	Lapatinib ditosylate hydrate LAPATINIB DITOSYLATE MONOHYDRATE Tykerb Tyverb
Research Area	Anti-Tumor APIs
Molecular Formula	C43H44ClFN4O11S3
CAS#	388082-78-8
SMILES	CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.O
Size	inquiry
Supplier Page	https://www.protheragen-ing.com/lapatinib-ditosylate-monohydrate-item-12192.html